Edition:
India

People: Amneal Pharmaceuticals Inc (AMRX.N)

AMRX.N on New York Stock Exchange

3.82USD
24 Sep 2020
Change (% chg)

-- (--)
Prev Close
$3.82
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
308,789
52-wk High
$5.78
52-wk Low
$2.40

Saraf, Apurva 

Mr. Apurva Saraf serves as Senior Vice President - Corporate Development of the Company. Apurva leads Amneal’s Global Corporate Development function and is responsible for the company’s global strategic and business development initiatives. Apurva has been part of the extended executive leadership team since joining Amneal in 2012 and has broad experience in commercial operations across various channels and in negotiating and integrating M&A transactions globally. While at Amneal, Apurva also co-founded Gemini Laboratories, a successful specialty pharmaceuticals company. Prior to Amneal, Apurva served in positions of increasing responsibility, including head of North America business development, for Ranbaxy USA. Prior to Ranbaxy, Apurva was an equity analyst, with UBS, JPMorgan and Credit Suisse in New York, covering the Specialty and Generic Pharmaceuticals sector.

Basic Compensation

Total Annual Compensation, --
Restricted Stock Award, --
Long-Term Incentive Plans, --
All Other, --
Fiscal Year Total, --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --